Microbices: the case for Europe.
|dc.contributor.author||Cairde [Challenging ethnic minority health inequalities]|
|dc.identifier.citation||Cairde. 2002. Microbices: the case for Europe. Dublin: Cairde.||en|
|dc.description||[Abstract from publication] Since then a rising tide of voices have joined this chorus. More than two decades into the AIDS epidemic, the world is still dependent on the male or female condom for preventing disease. Regrettably, neither is a viable option for many individuals around the world. Given the social, political, and economic forces that condition people's risk, individuals need and want a wider array of tools to enhance their own protection One approach on the horizon that deserves increased public and private sector support is topical microbicides. At the present rate of progress, however, it will be 10 years or more before a safe, effective and affordable microbicide becomes available to women and men worldwide. Reducing this time frame will require global political commitment, new thinking, and collaboration between scientists, donors, industry and advocates in both industrial and developing countries.||en|
|dc.title||Microbices: the case for Europe.||en|